Search Result "LINE-1 hypomethylation"
Clinical Advances in Hypomethylating Agents Targeting Epigenetic Pathways
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 5 Year: 2010 Page: 539-545
Author(s): S. Cang, Q. Lu, Y. Ma, D. Liu
LINE-1 Methylation is Associated with an Increased Risk of Ischemic Stroke in Men
Journal: Current Neurovascular Research
Volume: 11 Issue: 1 Year: 2014 Page: 4-9
Author(s): Reuy-Tay Lin,Edward Hsi,Hsiu-Fen Lin,Yi-Chu Liao,Yung-Song Wang,Suh-Hang H. Juo
Hypomethylation and Activation of Syncytin-1 Gene in Endometriotic Tissue
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 1 Year: 2014 Page: 1786-1795
Author(s): Hongyuan Zhou, Jinping Li, Karl C. Podratz, Tracy Tipton, Susan Marzolf, Hai Bin Chen, Shi-Wen Jiang
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2349-2357
Author(s): Carlo Finelli, Matilde Y. Follo, Marta Stanzani, Sarah Parisi, Cristina Clissa, Sara Mongiorgi, Marilena Barraco, Lucio Cocco
Tissue-Specific Methylation of Long Interspersed Nucleotide Element-1 of Homo Sapiens (L1Hs) During Human Embryogenesis and Roles in Neural Tube Defects
Journal: Current Molecular Medicine
Volume: 15 Issue: 5 Year: 2015 Page: 497-507
Author(s): L. Wang,S. Chang,J. Guan,S. Shangguan,X. Lu,Z. Wang,L. Wu,J. Zou,H. Zhao,Y. Bao,Z. Qiu,B. Niu,T. Zhang
The Hypomethylation Agent Bisdemethoxycurcumin Acts on the WIF-1 Promoter, Inhibits the Canonical Wnt Pathway and Induces Apoptosis in Human Non-Small-Cell Lung Cancer
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1098-1110
Author(s): Y.-L. Liu, H.-P. Yang, X.-D. Zhou, L. Gong, C.-L. Tang, H.-J. Wang
Nutri-epigenomic Studies Related to Neural Tube Defects: Does Folate Affect Neural Tube Closure Via Changes in DNA Methylation?
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15 Issue: 13 Year: 2015 Page: 1095-1102
Author(s): Anne Rochtus,Katrien Jansen,Chris Van Geet,Kathleen Freson
Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 7 Year: 2005 Page: 471-488
Author(s): Pouya Pakneshan, Moshe Szyf, Shafaat A. Rabbani
The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Journal: Current Molecular Medicine
Volume: 11 Issue: 4 Year: 2011 Page: 286-303
Author(s): O. Piskareva, W. Lackington, D. Lemass, C. Hendrick, P. Doolan, N. Barron
DNMT Inhibitors in Cancer, Current Treatments and Future Promising Approach: Inhibition of Specific DNMT-Including Complexes
Journal: Epigenetic Diagnosis & Therapy
Volume: 1 Issue: 1 Year: 2015 Page: 37-48
Author(s): Mathilde Cheray, Romain Pacaud, Eric Hervouet, Francois M. Vallette, Pierre-Francois Cartron